| Year |
Citation |
Score |
| 2019 |
Greenwood HE, McCormick PN, Gendron T, Glaser M, Pereira R, Maddocks ODK, Sander K, Zhang T, Koglin N, Lythgoe MF, Årstad E, Hochhauser D, Witney TH. Measurement of tumor antioxidant capacity and prediction of chemotherapy resistance in preclinical models of ovarian cancer by positron emission tomography. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30651275 DOI: 10.1158/1078-0432.CCR-18-3423 |
0.544 |
|
| 2018 |
Pereira R, Gendron T, Sanghera C, Greenwood HE, Newcombe J, McCormick PN, Sander K, Topf M, Årstad E, Witney TH. Mapping Aldehyde Dehydrogenase 1A1 Activity using an [ F]Substrate-Based Approach. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 30521138 DOI: 10.1002/Chem.201805473 |
0.544 |
|
| 2018 |
McCormick PN, Greenwood HE, Glaser M, Maddocks ODK, Gendron T, Sander K, Gowrishankar G, Hoehne A, Zhang T, Shuhendler AJ, Lewis DY, Berndt M, Koglin N, Lythgoe MF, Gambhir SS, et al. Assessment of tumor redox status through (S)-4-(3-[18F]fluoropropyl)-L-glutamic acid positron emission tomography imaging of system xc- activity. Cancer Research. PMID 30401715 DOI: 10.1158/0008-5472.Can-18-2634 |
0.729 |
|
| 2013 |
Vasdev N, Green DE, Vines DC, McLarty K, McCormick PN, Moran MD, Houle S, Wilson AA, Reilly RM. Positron-emission tomography imaging of the TSPO with [18F]FEPPA in a preclinical breast cancer model Cancer Biotherapy and Radiopharmaceuticals. 28: 254-259. PMID 23350894 DOI: 10.1089/Cbr.2012.1196 |
0.567 |
|
| 2008 |
Wilson AA, Garcia A, Parkes J, McCormick P, Stephenson KA, Houle S, Vasdev N. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nuclear Medicine and Biology. 35: 305-14. PMID 18355686 DOI: 10.1016/J.Nucmedbio.2007.12.009 |
0.516 |
|
| Show low-probability matches. |